Prothymosin α Overexpression Contributes to the Development of Insulin Resistance.

CONCLUSIONS: Our results support the role for ProT in the development of insulin resistance. Therefore, ProT is a potential novel therapeutic target for type 2 diabetes. PMID: 26348351 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26348351?dopt=Abstract

Source: Diabetes Metab - September 8, 2015 Category: Endocrinology Authors: Su YC, Ou HY, Wu HT, Wu P, Chen YC, Su BH, Shiau AL, Chang CJ, Wu CL Tags: J Clin Endocrinol Metab Source Type: research